Is Immunovia AB (publ) (IMMNOV.ST) a Buy, Sell, or Hold?
Immunovia AB (publ)
STO:IMMNOV.ST
$0.846 SEK
$0.19 (29.75%)
- Volume
- 11.31M
- Average Volume
- 3.71M
- Market Capitalization
- $110.65M
- P/E Ratio
- -0.33
- Dividend Yield
- 0.00%
- Price Target
- $
- Year High
- $3.15
- Year Low
- $0.53
- Payout Ratio
- $0.00
- Current Ratio
- $1.10
Industry, Sector & symbol
| Stock Exchange | Stockholm Stock Exchange |
| CEO | Mr. Jeff Borcherding |
| Industry | Medical - Diagnostics & Research |
| Sector | Healthcare |
| Current Symbol | IMMNOV.ST |
| CUSIP | None |
| CIK | None |
| Web | https://www.immunovia.com |
| Phone | 46 4 62 75 60 00 |
| Currency | SEK |
| Employees | 10 |
| Country | SE |
Liquidity
| Debt-to-Equity Ratio | 0.00 |
| Payout Ratio | 0.00 |
| Current Ratio | 1.10 |
| Quick Ratio | 1.10 |
| Cash Ratio | 0.95 |
Sales & Book Value
| Annual Sales | $1.58M |
| Price / Sales | 125.03 |
| Cash Flow | -2.57 |
| Price / Cash Flow | -0.96 |
| Price / Book | 1.93 |
Price Target and Rating
| Average Stock Price Forecast | $ |
| High Stock Price Forecast | $ |
| Low Stock Price Forecast | $ |
| Forecast Upside/Downside | % |
| Consensus Rating | Strong Sell |
| Rating Score(0-5) | 1 |
| Research Coverage | 0 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-7.38 |
| Trailing P/E Ratio | -0.33 |
| PEG Ratio | -0.01 |
| P/E Growth | -0.01 |
| Net Income | $-309.44M |
| Net Margin | -13120.79% |
| Pretax Margin | -13120.79% |
| Return on Equity | -207.71% |
| Return on Assets | -199.28% |
Financials Score
| AltmanZ Score | -29.90 |
| Piotroski Score | 3.00 |
| Working Capital | 3.8M |
| Total Assets | 58.27M |
| Ebit | -98.68M |
| Market Cap | 110.65M |
| Total Liabilities | 38.56M |
Poll Results
About Immunovia AB (publ) (STO:IMMNOV.ST) Stock
Immunovia AB (publ), a diagnostic company, develops and commercializes blood tests in Sweden and internationally. The company's product includes IMMray PanCan-d, a blood-based test for the early detection of pancreatic cancer. It also develops research projects for lung cancer. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden. ...
Frequently Asked Questions
-
What is the current Immunovia AB (publ) (IMMNOV.ST) stock price?
-
Immunovia AB (publ)(STO:IMMNOV.ST) stock price is $0.846 in the last trading session. During the trading session, IMMNOV.ST stock reached the peak price of $3.15 while $0.526 was the lowest point it dropped to. The percentage change in IMMNOV.ST stock occurred in the recent session was 29.75% while the dollar amount for the price change in IMMNOV.ST stock was $0.19.
-
IMMNOV.ST's industry and sector of operation?
-
The STO listed IMMNOV.ST is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector.
-
Who are the executives of IMMNOV.ST?
-
Mr. Jeff Borcherding | Global Chief Executive Officer & President
Ms. Lara E. Sucheston-Campbell | Head of Clinical & Medical Affairs
Ms. Karin Almqvist Liwendahl | Chief Financial Officer
|
| -
How many employees does IMMNOV.ST have?
-
Number of IMMNOV.ST employees currently stands at 10. IMMNOV.ST operates from Medicon Village, Lund, None 223 63, SE.
-
Link for IMMNOV.ST official website?
-
Official Website of IMMNOV.ST is: https://www.immunovia.com
-
How do I contact IMMNOV.ST?
-
IMMNOV.ST could be contacted at phone #46 4 62 75 60 00 and can also be accessed through its website. IMMNOV.ST operates from Medicon Village, Lund, None 223 63, SE.
-
How many shares of IMMNOV.ST are traded daily?
-
The average number of IMMNOV.ST shares traded daily for last 3 months was 3.71M.
-
What is the market cap of IMMNOV.ST currently?
-
The market value of IMMNOV.ST currently stands at $110.65M with its latest stock price at $0.846